International Continence Society

Dr. Martin C. Michel was born and raised in Germany. After studying medicine in Essen (Germany) and Vienna (Austria) he received his medical degree in 1985. Based upon a thesis in the Dept. of Biochemistry of the University of Essen he received a doctorate in 1987. He has worked as a post-doc in Essen (1985-1987) and at the University of California San Diego (1987-1990) and was appointed as Adjunct Assistant Professor in San Diego and as lecturer in Essen in 1991. He is a board-certified pharmacologist (1990) and clinical pharmacologist (1997). Between 1993 and 2002 he was head of the Nephrology and Hypertension Research Laboratory at the University of Essen. From 2003-2011 he was professor and head of the Department of Pharmacology & Pharmacotherapy at the University of Amsterdam (The Netherlands) and from 2011-2016 Global Head Product and Pipeline Scientific Support at Boehringer Ingelheim. Currently, he is a Professor of Pharmacology at the Johannes Gutenberg University in Mainz, Germany. He is a member of many national and international pharmacological and urological societies. He also is past Editor-in-Chief of Naunyn-Schmiedeberg’s Archives of Pharmacology and serves on the board of many pharmacological, physiological and urological journals including Molecular Pharmacology, American Journal of Physiology (Cell Physiology) and European Urology. Dr. Michel has published more than 300 articles in peer-reviewed journals. His most important award/distinct was the election into the Academia Europaea, the European academy of sciences.

SYNOPSIS OF AREA OF INTEREST: Dr. Michel’s research interests include urogenital and cardiovascular pharmacology and physiology spanning the entire range from molecular pharmacology to clinical trials.